Shares of Jasper Therapeutics, Inc. (NASDAQ:JSPRW – Get Free Report) rose 20% during trading on Wednesday . The company traded as high as $0.09 and last traded at $0.11. Approximately 1,000 shares changed hands during mid-day trading, a decline of 87% from the average daily volume of 7,706 shares. The stock had previously closed at $0.09.
Jasper Therapeutics Stock Performance
The firm’s 50 day moving average is $0.11 and its 200 day moving average is $0.12.
About Jasper Therapeutics
Jasper Therapeutics, Inc, a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy.
Featured Articles
- Five stocks we like better than Jasper Therapeutics
- How to Invest in Small Cap Stocks
- RSI Stock Soars 22% On Q2 Blowout—Will PENN Match the Momentum?
- Market Cap Calculator: How to Calculate Market Cap
- How DigitalOcean’s Focus Is Fueling Explosive Growth
- Why Invest in 5G? How to Invest in 5G Stocks
- Can Celsius Stock Keep Its Momentum Going Any Longer?
Receive News & Ratings for Jasper Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jasper Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
